| Dr Kyle William Siewert, MD | |
|
2200 Forest Ridge Pkwy, Suite 240, New Castle, IN 47362-2943 | |
| (765) 521-7385 | |
| (765) 521-7394 |
| Full Name | Dr Kyle William Siewert |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 17 Years |
| Location | 2200 Forest Ridge Pkwy, New Castle, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336349141 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 01071193A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hcmh Home Care | New castle, IN | Home health agency |
| Kindred At Home | Muncie, IN | Home health agency |
| Reid-anc Home Care Services Llc | Richmond, IN | Home health agency |
| Henry County Memorial Hospital | New castle, IN | Hospital |
| Reid Hospital & Health Care Services | Richmond, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cutting Edge Physical Therapy Limited Partnership | 6406869163 | 35 |
| New Castle Clinic Inc | 3274528757 | 37 |
News Archive
MedStar Washington Hospital Center now offers Blue Light Cystoscopy with Cysview, a new, FDA-approved technology used to pinpoint bladder tumors in patients with known or suspected bladder cancer.
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has initiated dosing in a multicenter (USA), randomized, placebo and active comparator controlled Phase 2b study that will enroll approximately 600 patients with type 2 diabetes (hemoglobin A1c 7% - 11%) inadequately controlled with diet and exercise, metformin, a sulfonylurea or a combination of metformin/sulfonylurea.
In the early stages of Alzheimer's disease, patients typically suffer a major loss of the brain connections necessary for memory and information processing. Now, a combination of nutrients that was developed at MIT has shown the potential to improve memory in Alzheimer's patients by stimulating growth of new brain connections.
Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announces the publication of "Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting" in PLoS ONE.
› Verified 1 days ago
| Entity Name | Henry County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891570537 PECOS PAC ID: 6002724085 Enrollment ID: O20031121000221 |
News Archive
MedStar Washington Hospital Center now offers Blue Light Cystoscopy with Cysview, a new, FDA-approved technology used to pinpoint bladder tumors in patients with known or suspected bladder cancer.
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has initiated dosing in a multicenter (USA), randomized, placebo and active comparator controlled Phase 2b study that will enroll approximately 600 patients with type 2 diabetes (hemoglobin A1c 7% - 11%) inadequately controlled with diet and exercise, metformin, a sulfonylurea or a combination of metformin/sulfonylurea.
In the early stages of Alzheimer's disease, patients typically suffer a major loss of the brain connections necessary for memory and information processing. Now, a combination of nutrients that was developed at MIT has shown the potential to improve memory in Alzheimer's patients by stimulating growth of new brain connections.
Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announces the publication of "Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting" in PLoS ONE.
› Verified 1 days ago
| Entity Name | New Castle Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801964960 PECOS PAC ID: 3274528757 Enrollment ID: O20041111000692 |
News Archive
MedStar Washington Hospital Center now offers Blue Light Cystoscopy with Cysview, a new, FDA-approved technology used to pinpoint bladder tumors in patients with known or suspected bladder cancer.
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has initiated dosing in a multicenter (USA), randomized, placebo and active comparator controlled Phase 2b study that will enroll approximately 600 patients with type 2 diabetes (hemoglobin A1c 7% - 11%) inadequately controlled with diet and exercise, metformin, a sulfonylurea or a combination of metformin/sulfonylurea.
In the early stages of Alzheimer's disease, patients typically suffer a major loss of the brain connections necessary for memory and information processing. Now, a combination of nutrients that was developed at MIT has shown the potential to improve memory in Alzheimer's patients by stimulating growth of new brain connections.
Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announces the publication of "Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting" in PLoS ONE.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kyle William Siewert, MD Po Box 530, New Castle, IN 47362-0530 Ph: (765) 521-7385 | Dr Kyle William Siewert, MD 2200 Forest Ridge Pkwy, Suite 240, New Castle, IN 47362-2943 Ph: (765) 521-7385 |
News Archive
MedStar Washington Hospital Center now offers Blue Light Cystoscopy with Cysview, a new, FDA-approved technology used to pinpoint bladder tumors in patients with known or suspected bladder cancer.
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has initiated dosing in a multicenter (USA), randomized, placebo and active comparator controlled Phase 2b study that will enroll approximately 600 patients with type 2 diabetes (hemoglobin A1c 7% - 11%) inadequately controlled with diet and exercise, metformin, a sulfonylurea or a combination of metformin/sulfonylurea.
In the early stages of Alzheimer's disease, patients typically suffer a major loss of the brain connections necessary for memory and information processing. Now, a combination of nutrients that was developed at MIT has shown the potential to improve memory in Alzheimer's patients by stimulating growth of new brain connections.
Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announces the publication of "Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting" in PLoS ONE.
› Verified 1 days ago
Clayton Edward Strong, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2200 Forest Ridge Pkwy, Suite 240, New Castle, IN 47362 Phone: 765-521-7385 Fax: 765-521-7394 | |
Anjan P Kaushik, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2200 Forest Ridge Pkwy, New Castle, IN 47362 Phone: 765-521-7385 | |
Dr. Lindsey R Rolston, M.D Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2200 Forest Ridge Pkwy, Suite #240, New Castle, IN 47362 Phone: 765-521-7385 Fax: 765-521-7394 | |
Dr. Thomas J. Mathews, M.D Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2200 Forest Ridge Pkwy, Suite #240, New Castle, IN 47362 Phone: 765-521-7385 Fax: 765-521-7394 | |
Dr. Damion M. Harris, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2200 Forest Ridge Pkwy, Suite #240, New Castle, IN 47362 Phone: 765-521-7385 Fax: 765-521-7394 |